Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dronabinol vs Ondansetron for Delayed CINV
NCT00642512Phase 3Completed
- Sponsor
- Solvay
- Start
- Jul 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dronabinol in chemotherapy-induced nausea and vomiting (CINV) (4 arms), sponsored by Solvay. Primary endpoint: Total response of nausea and vomiting/retching at 5 days. Started Jul 2003; status: completed.
02
Drugs
dronabinol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00642512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642512.